位置:首页 > 蛋白库 > SAHH3_HUMAN
SAHH3_HUMAN
ID   SAHH3_HUMAN             Reviewed;         611 AA.
AC   Q96HN2; B4DIZ5; D9N155; O94917;
DT   11-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   03-AUG-2022, entry version 166.
DE   RecName: Full=Adenosylhomocysteinase 3;
DE            Short=AdoHcyase 3;
DE            EC=3.3.1.1;
DE   AltName: Full=IP(3)Rs binding protein released with IP(3) 2;
DE            Short=IRBIT2;
DE   AltName: Full=Long-IRBIT {ECO:0000303|PubMed:19220705};
DE   AltName: Full=S-adenosyl-L-homocysteine hydrolase 3;
DE   AltName: Full=S-adenosylhomocysteine hydrolase-like protein 2;
GN   Name=AHCYL2; Synonyms=KIAA0828;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Colon mucosa, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-107, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   FUNCTION, INTERACTION WITH AHCYL1, INTERACTION WITH ITPR1, AND
RP   PHOSPHORYLATION AT SER-149; SER-152; SER-155 AND SER-158.
RX   PubMed=19220705; DOI=10.1111/j.1471-4159.2009.05979.x;
RA   Ando H., Mizutani A., Mikoshiba K.;
RT   "An IRBIT homologue lacks binding activity to inositol 1,4,5-trisphosphate
RT   receptor due to the unique N-terminal appendage.";
RL   J. Neurochem. 109:539-550(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-107, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-107, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   INTERACTION WITH ZCCHC4.
RX   PubMed=31799605; DOI=10.1093/nar/gkz1147;
RA   Pinto R., Vaagboe C.B., Jakobsson M.E., Kim Y., Baltissen M.P.,
RA   O'Donohue M.F., Guzman U.H., Malecki J.M., Wu J., Kirpekar F., Olsen J.V.,
RA   Gleizes P.E., Vermeulen M., Leidel S.A., Slupphaug G., Falnes P.O.;
RT   "The human methyltransferase ZCCHC4 catalyses N6-methyladenosine
RT   modification of 28S ribosomal RNA.";
RL   Nucleic Acids Res. 48:830-846(2020).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 175-607 IN COMPLEX WITH NAD, AND
RP   SUBUNIT.
RG   Structural genomics consortium (SGC);
RT   "Human S-adenosyl homocysteine hydrolase-like 2 protein crystal
RT   structure.";
RL   Submitted (JUN-2009) to the PDB data bank.
CC   -!- FUNCTION: May regulate the electrogenic sodium/bicarbonate
CC       cotransporter SLC4A4 activity and Mg(2+)-sensitivity. On the contrary
CC       of its homolog AHCYL1, does not regulate ITPR1 sensitivity to inositol
CC       1,4,5-trisphosphate (PubMed:19220705). {ECO:0000250|UniProtKB:A6QLP2,
CC       ECO:0000269|PubMed:19220705}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + S-adenosyl-L-homocysteine = adenosine + L-homocysteine;
CC         Xref=Rhea:RHEA:21708, ChEBI:CHEBI:15377, ChEBI:CHEBI:16335,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:58199; EC=3.3.1.1;
CC   -!- COFACTOR:
CC       Name=NAD(+); Xref=ChEBI:CHEBI:57540;
CC       Note=Binds 1 NAD(+) per subunit.;
CC   -!- PATHWAY: Amino-acid biosynthesis; L-homocysteine biosynthesis; L-
CC       homocysteine from S-adenosyl-L-homocysteine: step 1/1.
CC   -!- SUBUNIT: Homotetramer (Probable). Forms heteromultimers with AHCYL1
CC       (via the C-terminal region) (PubMed:19220705). Interacts with ITPR1;
CC       with lower affinity than AHCYL1 and maybe via ITPR1 (PubMed:19220705).
CC       Interacts with SLC4A4 (By similarity). Interacts with ZCCHC4
CC       (PubMed:31799605). {ECO:0000250|UniProtKB:A6QLP2,
CC       ECO:0000269|PubMed:19220705, ECO:0000269|PubMed:31799605,
CC       ECO:0000305|Ref.12}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:A6QLP2,
CC       ECO:0000250|UniProtKB:Q68FL4}. Microsome
CC       {ECO:0000250|UniProtKB:Q68FL4}. Note=Associates with membranes when
CC       phosphorylated, probably through interaction with ITPR1.
CC       {ECO:0000250|UniProtKB:Q68FL4}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q96HN2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96HN2-2; Sequence=VSP_040095;
CC       Name=3;
CC         IsoId=Q96HN2-3; Sequence=VSP_043185, VSP_043186;
CC       Name=4;
CC         IsoId=Q96HN2-4; Sequence=VSP_046278, VSP_046279;
CC   -!- PTM: Phosphorylated during neuronal differentiation at the LISN domain.
CC       {ECO:0000250|UniProtKB:Q68FL4}.
CC   -!- SIMILARITY: Belongs to the adenosylhomocysteinase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74851.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB020635; BAA74851.1; ALT_INIT; mRNA.
DR   EMBL; AK025372; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK295851; BAG58657.1; -; mRNA.
DR   EMBL; AK316073; BAH14444.1; -; mRNA.
DR   EMBL; AC009244; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011005; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083866; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093149; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008349; AAH08349.1; -; mRNA.
DR   EMBL; BC024325; AAH24325.1; -; mRNA.
DR   CCDS; CCDS47706.1; -. [Q96HN2-2]
DR   CCDS; CCDS47707.2; -. [Q96HN2-3]
DR   CCDS; CCDS47708.1; -. [Q96HN2-4]
DR   CCDS; CCDS5812.1; -. [Q96HN2-1]
DR   RefSeq; NP_001124192.1; NM_001130720.2. [Q96HN2-2]
DR   RefSeq; NP_001124194.2; NM_001130722.2. [Q96HN2-3]
DR   RefSeq; NP_001124195.1; NM_001130723.2. [Q96HN2-4]
DR   RefSeq; NP_056143.1; NM_015328.3. [Q96HN2-1]
DR   PDB; 3GVP; X-ray; 2.25 A; A/B/C/D=175-607.
DR   PDBsum; 3GVP; -.
DR   AlphaFoldDB; Q96HN2; -.
DR   SMR; Q96HN2; -.
DR   BioGRID; 116958; 138.
DR   IntAct; Q96HN2; 68.
DR   MINT; Q96HN2; -.
DR   STRING; 9606.ENSP00000315931; -.
DR   iPTMnet; Q96HN2; -.
DR   PhosphoSitePlus; Q96HN2; -.
DR   BioMuta; AHCYL2; -.
DR   DMDM; 21759427; -.
DR   EPD; Q96HN2; -.
DR   jPOST; Q96HN2; -.
DR   MassIVE; Q96HN2; -.
DR   MaxQB; Q96HN2; -.
DR   PaxDb; Q96HN2; -.
DR   PeptideAtlas; Q96HN2; -.
DR   PRIDE; Q96HN2; -.
DR   ProteomicsDB; 15179; -.
DR   ProteomicsDB; 76768; -. [Q96HN2-1]
DR   ProteomicsDB; 76769; -. [Q96HN2-2]
DR   ProteomicsDB; 76770; -. [Q96HN2-3]
DR   Antibodypedia; 17876; 70 antibodies from 18 providers.
DR   DNASU; 23382; -.
DR   Ensembl; ENST00000325006.8; ENSP00000315931.3; ENSG00000158467.17. [Q96HN2-1]
DR   Ensembl; ENST00000446544.6; ENSP00000413639.2; ENSG00000158467.17. [Q96HN2-2]
DR   Ensembl; ENST00000474594.5; ENSP00000420459.1; ENSG00000158467.17. [Q96HN2-4]
DR   Ensembl; ENST00000490911.5; ENSP00000420801.1; ENSG00000158467.17. [Q96HN2-3]
DR   GeneID; 23382; -.
DR   KEGG; hsa:23382; -.
DR   MANE-Select; ENST00000325006.8; ENSP00000315931.3; NM_015328.4; NP_056143.1.
DR   UCSC; uc003vot.4; human. [Q96HN2-1]
DR   CTD; 23382; -.
DR   DisGeNET; 23382; -.
DR   GeneCards; AHCYL2; -.
DR   HGNC; HGNC:22204; AHCYL2.
DR   HPA; ENSG00000158467; Group enriched (choroid plexus, intestine).
DR   MIM; 616520; gene.
DR   neXtProt; NX_Q96HN2; -.
DR   OpenTargets; ENSG00000158467; -.
DR   PharmGKB; PA162376046; -.
DR   VEuPathDB; HostDB:ENSG00000158467; -.
DR   eggNOG; KOG1370; Eukaryota.
DR   GeneTree; ENSGT00950000182981; -.
DR   HOGENOM; CLU_025194_2_1_1; -.
DR   InParanoid; Q96HN2; -.
DR   OMA; QPTHLCE; -.
DR   OrthoDB; 371693at2759; -.
DR   PhylomeDB; Q96HN2; -.
DR   TreeFam; TF300415; -.
DR   PathwayCommons; Q96HN2; -.
DR   Reactome; R-HSA-425381; Bicarbonate transporters.
DR   SignaLink; Q96HN2; -.
DR   SIGNOR; Q96HN2; -.
DR   UniPathway; UPA00314; UER00076.
DR   BioGRID-ORCS; 23382; 10 hits in 1074 CRISPR screens.
DR   ChiTaRS; AHCYL2; human.
DR   EvolutionaryTrace; Q96HN2; -.
DR   GenomeRNAi; 23382; -.
DR   Pharos; Q96HN2; Tbio.
DR   PRO; PR:Q96HN2; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q96HN2; protein.
DR   Bgee; ENSG00000158467; Expressed in rectum and 173 other tissues.
DR   ExpressionAtlas; Q96HN2; baseline and differential.
DR   Genevisible; Q96HN2; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-KW.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0033353; P:S-adenosylmethionine cycle; IBA:GO_Central.
DR   CDD; cd00401; SAHH; 1.
DR   Gene3D; 3.40.50.1480; -; 3.
DR   InterPro; IPR042172; Adenosylhomocyst_ase-like_sf.
DR   InterPro; IPR000043; Adenosylhomocysteinase-like.
DR   InterPro; IPR015878; Ado_hCys_hydrolase_NAD-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020082; S-Ado-L-homoCys_hydrolase_CS.
DR   PANTHER; PTHR23420; PTHR23420; 1.
DR   Pfam; PF05221; AdoHcyase; 1.
DR   Pfam; PF00670; AdoHcyase_NAD; 1.
DR   SMART; SM00996; AdoHcyase; 1.
DR   SMART; SM00997; AdoHcyase_NAD; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR00936; ahcY; 1.
DR   PROSITE; PS00738; ADOHCYASE_1; 1.
DR   PROSITE; PS00739; ADOHCYASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm;
KW   Endoplasmic reticulum; Hydrolase; Microsome; NAD; One-carbon metabolism;
KW   Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895"
FT   CHAIN           2..611
FT                   /note="Adenosylhomocysteinase 3"
FT                   /id="PRO_0000116909"
FT   REGION          1..184
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2..109
FT                   /note="LISN domain, inhibits interaction with ITPR1"
FT                   /evidence="ECO:0000269|PubMed:19220705"
FT   COMPBIAS        48..68
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        86..104
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        142..166
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         236
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         310
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         335
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         336..338
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
FT   BINDING         365
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         369
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         370
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
FT   BINDING         401..406
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|Ref.12"
FT   BINDING         422
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|Ref.12"
FT   BINDING         457
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|Ref.12"
FT   BINDING         478..479
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|Ref.12"
FT   BINDING         525
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|Ref.12"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895"
FT   MOD_RES         107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         149
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:19220705"
FT   MOD_RES         152
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:19220705"
FT   MOD_RES         155
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:19220705"
FT   MOD_RES         158
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:19220705"
FT   VAR_SEQ         1..19
FT                   /note="MSVQVVSAAAAAKVPEVEL -> MEKWDGNEGTSAFHMPEWM (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046278"
FT   VAR_SEQ         1..18
FT                   /note="MSVQVVSAAAAAKVPEVE -> MLGSKKKYIVNGNSGIKA (in isoform
FT                   3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043185"
FT   VAR_SEQ         19..121
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043186"
FT   VAR_SEQ         20..122
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046279"
FT   VAR_SEQ         122
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10048485"
FT                   /id="VSP_040095"
FT   HELIX           191..193
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           194..206
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           209..218
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   TURN            223..226
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          228..233
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           237..248
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          252..261
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           265..274
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           286..297
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          305..312
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           313..321
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           323..327
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          331..334
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           337..343
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          356..358
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           363..369
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           371..386
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          394..398
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           402..413
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          417..421
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           425..433
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           441..444
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   TURN            445..447
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          449..453
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           463..468
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          473..477
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   TURN            481..484
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           487..490
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          496..501
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          504..508
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          514..518
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           519..521
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           524..528
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           533..552
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   TURN            555..557
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   STRAND          560..564
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           567..577
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           578..581
FT                   /evidence="ECO:0007829|PDB:3GVP"
FT   HELIX           590..596
FT                   /evidence="ECO:0007829|PDB:3GVP"
SQ   SEQUENCE   611 AA;  66721 MW;  A76B1275FC0D891D CRC64;
     MSVQVVSAAA AAKVPEVELK DLSPSEAESQ LGLSTAAVGA MAPPAGGGDP EAPAPAAERP
     PVPGPGSGPA AALSPAAGKV PQASAMKRSD PHHQHQRHRD GGEALVSPDG TVTEAPRTVK
     KQIQFADQKQ EFNKRPTKIG RRSLSRSISQ SSTDSYSSAA SYTDSSDDET SPRDKQQKNS
     KGSSDFCVKN IKQAEFGRRE IEIAEQEMPA LMALRKRAQG EKPLAGAKIV GCTHITAQTA
     VLMETLGALG AQCRWAACNI YSTLNEVAAA LAESGFPVFA WKGESEDDFW WCIDRCVNVE
     GWQPNMILDD GGDLTHWIYK KYPNMFKKIK GIVEESVTGV HRLYQLSKAG KLCVPAMNVN
     DSVTKQKFDN LYCCRESILD GLKRTTDMMF GGKQVVVCGY GEVGKGCCAA LKAMGSIVYV
     TEIDPICALQ ACMDGFRLVK LNEVIRQVDI VITCTGNKNV VTREHLDRMK NSCIVCNMGH
     SNTEIDVASL RTPELTWERV RSQVDHVIWP DGKRIVLLAE GRLLNLSCST VPTFVLSITA
     TTQALALIEL YNAPEGRYKQ DVYLLPKKMD EYVASLHLPT FDAHLTELTD EQAKYLGLNK
     NGPFKPNYYR Y
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024